Doctors examine a tumor in several different ways to determine whether a cancer is aggressive – and what kinds of treatments, if any, might work best.

Nodules can be cancerous or non-cancerous, according to the National Cancer Institute. ABC News reports that it is too early to determine whether Biden’s nodule is “a benign lump caused by ...

Six doctors who specialize in prostate cancer discuss what President Biden's recent diagnosis does and doesn't mean for his ...

Newly released audio recordings from President Biden's 2023 interview with Special Counsel Robert Hur reveal memory lapses concerning significant events, including the death of his son Beau and ...

President Trump on Saturday blasted his predecessor after leaked audio showed former President Biden struggling during a 2023 interview with then-special counsel Robert Hur about classified ...

including the year his son Beau died of cancer — 2015. Biden and his aides fiercely objected to Hur’s report, which they characterized as a partisan hit. Biden at that time — early 2024 ...

On May 13, several anecdotal stories emerged from CNN journalist Jake Tapper’s new book about the "cover-up" of former President Joe Biden’s mental decline. Those stories and that book are ...

The House Oversight Chair says he has identified staffers who may have signed off on major presidential actions during Joe Biden’s final month in office. Night Reporter House Oversight Chair ...

In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, researchers from Moffitt Cancer Center, University of Pennsylvania, University of ...

Audio of then-President Joe Biden’s interview with former special counsel Robert Hur in the now-closed probe over Biden’s handling of classified documents was published by Axios on Friday.

Rep. Ro Khanna, D-Calif., has noted that it is now "obvious" to him that then-President Joe Biden "was not in a condition to run for re-election." "To rebuild trust, Democrats must be honest.

Delhi, May 15, 2025 (GLOBE NEWSWIRE) -- US Orphan Designated Drugs Market Opportunity, Drugs Sales, Price, Dosage and Clinical Trials Insight 2030 ... rare cancer therapies are now a center ...